Document Detail

Adipocytokines, cardiovascular pathophysiology and myocardial protection.
MedLine Citation:
PMID:  20920528     Owner:  NLM     Status:  MEDLINE    
Reducing myocardial damage resulting from ischaemia-reperfusion (I/R) is vital in ensuring patient recovery and survival. It relies upon the activation of the so-called Reperfusion Injury Salvage Kinase (RISK) pathway. Experimentally various treatments, both mechanical and chemical, have been shown to protect the myocardium against I/R injury. Chemical facilitators of myocardial preservation include endogenous factors such as insulin, erythropoietin and glucagon-like peptide 1. The adipocytokines, products of white adipose tissue, are important peptide hormones with respect to metabolic control and satiety, and were formerly considered in the context of obesity and metabolic disease. More recently, however, evidence has been presented indicating that the adipocytokines play significant roles in cardiac function and, as we have suggested, in myocardial protection. To date leptin, adiponectin, apelin and visfatin have all been shown to protect against I/R injury. Significantly, the protection afforded by these peptides involves the activation of kinases which are key elements of the mechanisms underlying tissue preservation, including the RISK pathway components PI3K-Akt and p44/42, and inhibition of the mitochondrial permeability transition pore (MPTP). In this article we examine the roles played by the adipocytokines in cardiovascular function and disease. In particular, we focus on the evidence that these peptides promote myocardial survival, much of it having been obtained in this laboratory. To conclude, we discuss some future directions in the field, including the prospects for some of the adipocytokines finding application as therapeutic agents in myocardial infarction.
Christopher C T Smith; Derek M Yellon
Related Documents :
15991998 - Potential therapeutic applications of fructose-1,6-diphosphate.
15063358 - Pharmacological therapy for myocardial reperfusion injury.
18989538 - The synthetic pentasaccharide fondaparinux prevents coronary microvascular injury and m...
21943888 - Histological correlate of a cardiac magnetic resonance imaged microvascular obstruction...
21127708 - Genetic variation of vkorc1 and cyp4f2 genes related to warfarin maintenance dose in pa...
18706898 - No association found between the insertion/deletion of a 287-bp alu repeat sequence wit...
Publication Detail:
Type:  Journal Article; Review     Date:  2010-10-16
Journal Detail:
Title:  Pharmacology & therapeutics     Volume:  129     ISSN:  1879-016X     ISO Abbreviation:  Pharmacol. Ther.     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-01-24     Completed Date:  2011-05-24     Revised Date:  2014-02-20    
Medline Journal Info:
Nlm Unique ID:  7905840     Medline TA:  Pharmacol Ther     Country:  England    
Other Details:
Languages:  eng     Pagination:  206-19     Citation Subset:  IM    
Copyright Information:
Copyright © 2010 Elsevier Inc. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adipokines / chemistry,  metabolism*
Adiponectin / chemistry,  metabolism*
Cardiovascular System / physiopathology*
Leptin / chemistry,  metabolism*
Myocardial Reperfusion Injury / metabolism*,  prevention & control*
Myocardium / metabolism*,  pathology
Obesity / genetics,  metabolism
Signal Transduction
Grant Support
RG/08/015/26411//British Heart Foundation
Reg. No./Substance:
0/Adipokines; 0/Adiponectin; 0/Leptin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Alkhumra (Alkhurma) virus outbreak in Najran, Saudi Arabia: Epidemiological, clinical, and Laborator...
Next Document:  Roles of prostanoids in the pathogenesis of cardiovascular diseases: Novel insights from knockout mo...